Logo image of IRNT

IRONNET INC (IRNT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:IRNT - US46323Q1058 - Common Stock

0.127 USD
-0.01 (-6.55%)
Last: 8/4/2023, 8:11:34 PM
0.13 USD
+0 (+2.36%)
After Hours: 8/4/2023, 8:11:34 PM
Fundamental Rating

1

IRNT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 276 industry peers in the Software industry. IRNT may be in some trouble as it scores bad on both profitability and health. IRNT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

IRNT had negative earnings in the past year.
In the past year IRNT has reported a negative cash flow from operations.
IRNT Yearly Net Income VS EBIT VS OCF VS FCFIRNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -50M -100M -150M -200M

1.2 Ratios

The profitability ratios for IRNT are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IRNT Yearly ROA, ROE, ROICIRNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 500 -500 -1K -1.5K

1.3 Margins

IRNT has a worse Gross Margin (33.25%) than 81.79% of its industry peers.
In the last couple of years the Gross Margin of IRNT has declined.
IRNT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.2%
GM growth 5YN/A
IRNT Yearly Profit, Operating, Gross MarginsIRNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -200 -400 -600 -800

0

2. Health

2.1 Basic Checks

IRNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IRNT has been increased compared to 1 year ago.
Compared to 1 year ago, IRNT has a worse debt to assets ratio.
IRNT Yearly Shares OutstandingIRNT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M 100M
IRNT Yearly Total Debt VS Total AssetsIRNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

IRNT has an Altman-Z score of -32.87. This is a bad value and indicates that IRNT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -32.87, IRNT is doing worse than 95.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -32.87
ROIC/WACCN/A
WACC10.18%
IRNT Yearly LT Debt VS Equity VS FCFIRNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 20M -20M -40M -60M -80M

2.3 Liquidity

IRNT has a Current Ratio of 0.38. This is a bad value and indicates that IRNT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.38, IRNT is not doing good in the industry: 94.64% of the companies in the same industry are doing better.
A Quick Ratio of 0.33 indicates that IRNT may have some problems paying its short term obligations.
IRNT has a Quick ratio of 0.33. This is amonst the worse of the industry: IRNT underperforms 95.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.33
IRNT Yearly Current Assets VS Current LiabilitesIRNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M

2

3. Growth

3.1 Past

IRNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 59.06%, which is quite impressive.
Looking at the last year, IRNT shows a very negative growth in Revenue. The Revenue has decreased by -19.64% in the last year.
The Revenue has been growing slightly by 5.58% on average over the past years.
EPS 1Y (TTM)59.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.49%
Revenue 1Y (TTM)-19.64%
Revenue growth 3Y5.58%
Revenue growth 5YN/A
Sales Q2Q%-14.73%

3.2 Future

The Earnings Per Share is expected to grow by 24.90% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -0.78% on average over the next years.
EPS Next Y33.33%
EPS Next 2Y24.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.95%
Revenue Next 2Y-0.78%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IRNT Yearly Revenue VS EstimatesIRNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
IRNT Yearly EPS VS EstimatesIRNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 -0.2 -0.4 -0.6 -0.8

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IRNT. In the last year negative earnings were reported.
Also next year IRNT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IRNT Price Earnings VS Forward Price EarningsIRNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IRNT Per share dataIRNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as IRNT's earnings are expected to grow with 24.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.9%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

IRNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

IRONNET INC

NYSE:IRNT (8/4/2023, 8:11:34 PM)

After market: 0.13 +0 (+2.36%)

0.127

-0.01 (-6.55%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)06-15 2023-06-15
Earnings (Next)09-12 2023-09-12
Inst Owners0%
Inst Owner Change0%
Ins Owners26.14%
Ins Owner Change0%
Market Cap14.20M
Revenue(TTM)27.26M
Net Income(TTM)-111.01M
Analysts36.67
Price Target0.15 (18.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.28%
Min Revenue beat(2)8.29%
Max Revenue beat(2)10.28%
Revenue beat(4)2
Avg Revenue beat(4)-0.55%
Min Revenue beat(4)-14.19%
Max Revenue beat(4)10.28%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.52
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.08
EYN/A
EPS(NY)-0.51
Fwd EYN/A
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)-0.58
OCFYN/A
SpS0.24
BVpS-0.31
TBVpS-0.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.25%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.2%
GM growth 5YN/A
F-Score4
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.08%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.33
Altman-Z -32.87
F-Score4
WACC10.18%
ROIC/WACCN/A
Cap/Depr(3y)147.77%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)59.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.49%
EPS Next Y33.33%
EPS Next 2Y24.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-19.64%
Revenue growth 3Y5.58%
Revenue growth 5YN/A
Sales Q2Q%-14.73%
Revenue Next Year-1.95%
Revenue Next 2Y-0.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y49.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year37.48%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.48%
OCF growth 3YN/A
OCF growth 5YN/A

IRONNET INC / IRNT FAQ

What is the fundamental rating for IRNT stock?

ChartMill assigns a fundamental rating of 1 / 10 to IRNT.


Can you provide the valuation status for IRONNET INC?

ChartMill assigns a valuation rating of 1 / 10 to IRONNET INC (IRNT). This can be considered as Overvalued.


Can you provide the profitability details for IRONNET INC?

IRONNET INC (IRNT) has a profitability rating of 0 / 10.


Can you provide the financial health for IRNT stock?

The financial health rating of IRONNET INC (IRNT) is 0 / 10.


What is the earnings growth outlook for IRONNET INC?

The Earnings per Share (EPS) of IRONNET INC (IRNT) is expected to grow by 33.33% in the next year.